Escitalopram in Adult Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a short-term study to evaluate the efficacy, safety, and tolerability of escitalopram
in adult patients (18 to 65 years of age) with moderate to severe depression. Patients
completing the study may be eligible to enter a long-term open-label extension study with
escitalopram.